Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms
Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms
Comments are closed.